​

Abeona Therapeutics (ABEO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ABEO Stock Forecast

Abeona Therapeutics (ABEO) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 10.09% increase from the last price of $5.45.

High: $6 Avg: $6 Low: $6 Last Closed Price: $5.45

ABEO Stock Rating

Abeona Therapeutics stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (66.67%), 1 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 1 2 0 Strong Sell Sell Hold Buy Strong Buy

ABEO Forecast vs Benchmarks

TypeNameUpside
StockAbeona Therapeutics10.09%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$5.45$5.45$5.45
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2514---5
Dec, 2414---5
Nov, 2426---8
Oct, 2426---8
Sep, 2426---8
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2022Leerink Partners$6.00$4.1544.58%10.09%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jul 03, 2024H.C. WainwrightBuyinitialise
May 16, 2024Cantor FitzgeraldOverweightOverweighthold
Nov 14, 2022SVB LeerinkMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

$-35 $-25 $-15 $-5 $5 $15 Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.84$-4.05$-2.53-----
Avg Forecast$-20.58$-3.92$-2.23$-1.65$-1.19$-0.39$1.50$4.09
High Forecast$-32.90$-6.44$-3.44$-1.72$-1.48$-0.87$-9.86$2.89
Low Forecast$-9.48$-2.80$-1.58$-1.57$-0.99$-0.08$12.86$6.31
Surprise %15.84%3.32%13.45%-----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.00M$1.41M$3.50M-----
Avg Forecast$12.37M$2.32M$3.63M$125.00K$19.78M$75.92M$217.60M$397.20M
High Forecast$7.23M$1.81M$2.81M$96.89K$16.06M$58.85M$168.67M$307.88M
Low Forecast$18.06M$3.48M$5.14M$177.22K$26.88M$107.63M$308.50M$563.12M
Surprise %-19.14%-39.13%-3.45%-----

Net Income Forecast

$-750M $-540M $-330M $-120M $90M $300M Dec 20 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-88.35M$-31.81M$-54.19M-----
Avg Forecast$-440.08M$-83.70M$-54.19M$-35.13M$-26.38M$-10.18M$8.95M$87.45M
High Forecast$-703.51M$-137.68M$-73.57M$-36.69M$-31.62M$-18.66M$-210.75M$61.88M
Low Forecast$-202.61M$-59.77M$-33.74M$-33.58M$-21.15M$-1.70M$274.89M$134.93M
Surprise %-79.92%-62.00%------

ABEO Forecast FAQ

Is Abeona Therapeutics stock a buy?

Abeona Therapeutics stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Abeona Therapeutics is a favorable investment for most analysts.

What is Abeona Therapeutics's price target?

Abeona Therapeutics's price target, set by 3 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 10.09% change from the previous close price of $5.45.

How does Abeona Therapeutics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Abeona Therapeutics stock forecast shows a 10.09% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Abeona Therapeutics over the past three months?

  • January 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Abeona Therapeutics’s EPS forecast?

Abeona Therapeutics's average annual EPS forecast for its fiscal year ending in December is -1.65 for 2024, a -34.78% decrease from the reported $-2.53 in 2023. The prediction for 2025 is $-1.19, $-0.39 for 2026, $1.5 for 2027, and $4.09 for 2028.

What is Abeona Therapeutics’s revenue forecast?

Abeona Therapeutics's average annual revenue forecast for its fiscal year ending in December is $125K for 2024, a -96.43% decrease from the reported $3.5M in 2023. The forecast for 2025 is $19.78M, $75.92M for 2026, $217.6M for 2027, and $397.2M for 2028.

What is Abeona Therapeutics’s net income forecast?

For its fiscal year ending in December, Abeona Therapeutics's average annual net income forecast is $-35.131M for 2024, reflecting a -35.17% decrease from the reported $-54.188M in 2023. The projection for 2025 is $-26.383M, $-10.176M for 2026, $8.95M for 2027, and $87.45M for 2028.